Skip to main content
. 2014 Sep 16;24(10):1214–1230. doi: 10.1038/cr.2014.122

Table 1. Pathways enriched upon Bortezomib treatment.

Category Term P Value Genes Fold Enrichment FDR
BIOCARTA TSP-1 induced apoptosis in microvascular endothelial cell 2.86E-02 CD36, MAPK14, FOS 10.62 29.14
BIOCARTA Cytokines and inflammatory response 8.06E-02 CSF1, CSF2, IFNB1, IL6 3.81 63.19
BIOCARTA Bone remodeling 9.11E-02 IFNB1, Tnfsf11, FOS 5.72 67.88
KEGG_PATHWAY SNARE interactions in vesicular transport 2.36E-03 GOSR1, STX11, STX12, STX16, STX18, STX19, Use1 4.98 2.76
KEGG_PATHWAY Neuroactive ligand-receptor interaction 2.53E-02 HTR1B, Cnr2, FPR1, GABRA3, GABRA6, GLP1R, GLP2R, GLRA3, GHSR, NPBWR2, PTH1R, P2RX1, P2RX4, P2RY8, SSTR4, S1PR4, S1PR5 1.8 26.15
KEGG_PATHWAY Biosynthesis of unsaturated fatty acids 4.51E-02 Acot4, ACOT7, ACOX1, Acox3 4.92 42.05